|
CDK13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71219738176865E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.7579999939984E-09 |
| Normal-vs-Stage2 |
5.61399999999823E-05 |
| Normal-vs-Stage3 |
5.9688998188534E-10 |
| Normal-vs-Stage4 |
1.04980000248389E-08 |
| Stage1-vs-Stage2 |
7.834800E-01 |
| Stage1-vs-Stage3 |
7.766500E-02 |
| Stage1-vs-Stage4 |
1.366250E-01 |
| Stage2-vs-Stage3 |
1.586390E-01 |
| Stage2-vs-Stage4 |
1.595160E-01 |
| Stage3-vs-Stage4 |
9.116800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52159951305464E-10 |
| Normal-vs-AfricanAmerican |
1.278730E-03 |
| Normal-vs-Asian |
2.21059999999662E-05 |
| Caucasian-vs-AfricanAmerican |
4.975600E-01 |
| Caucasian-vs-Asian |
4.219000E-01 |
| AfricanAmerican-vs-Asian |
9.384000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15839999814682E-08 |
| Normal-vs-Female |
1.72689973432227E-10 |
| Male-vs-Female |
8.891600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0053000038267E-08 |
| Normal-vs-Age(41-60Yrs) |
3.09339998061375E-09 |
| Normal-vs-Age(61-80Yrs) |
1.00929999913291E-08 |
| Normal-vs-Age(81-100Yrs) |
3.042400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.637800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.767800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.792240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.677200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.391600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.802600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.803800E-04 |
| Classical-VS-Follicular |
9.242900E-03 |
| Classical-VS-Other |
3.130200E-01 |
| Classical-VS-Normal |
6.94539999956945E-08 |
| Tall-VS-Follicular |
1.943240E-01 |
| Tall-VS-Other |
5.667800E-01 |
| Tall-VS-Normal |
6.08070038765618E-10 |
| Follicular-VS-Other |
9.104600E-01 |
| Follicular-VS-Normal |
7.34950000857992E-09 |
| Other-VS-Normal |
5.996800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11950004821892E-09 |
| Normal-vs-N1 |
3.92410000049637E-07 |
| N0-vs-N1 |
8.505000E-01 |
|
|
